919 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Pharmaceuticals Has Bottomed This Time http://seekingalpha.com/article/4046306-teva-pharmaceuticals-bottomed-time?source=feed_tag_israel Feb 15, 2017 - Teva's management fielded calls that put its dividend into question. Suggestions that company should split signals the stock's undervaluation. Teva's growth ahead in generics and specialty overlooked:
Markets Climb Amid Solid Q4 Earnings http://www.zacks.com/stock/news/249222/markets-climb-amid-solid-q4-earnings?cid=CS-ZC-FT-249222 Feb 13, 2017 - Market futures are very positive this morning, and continue to climb 20 minutes before the opening bell sounds.
Teva's New Approach http://seekingalpha.com/article/3996426-tevas-new-approach?source=feed_tag_israel Aug 05, 2016 - Earlier last week, the Federal Trade Commission approved of Teva's acquisition of Allergan's generic pharma unit.Unsurprisingly, the +$40 Billion deal was closed this week.Teva's aggressive growth str
Stock Market News for August 05, 2016 http://www.zacks.com/stock/news/227074/stock-market-news-for-august-05-2016?cid=CS-ZC-FT-227074 Aug 05, 2016 - Benchmarks ended mostly flat on Thursday as investors refrained from making big bets ahead of Friday’s U.S. nonfarm payroll report
Teva Pharmaceutical Industries Limited 2016 Q2 - Results - Earnings Call Slides http://seekingalpha.com/article/3996333-teva-pharmaceutical-industries-limited-2016-q2-results-earnings-call-slides?source=feed_tag_israel Aug 05, 2016 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2016 Q2 earnings call.
Teva (TEVA) Beats on Q2 Earnings & Revenues, Stock Gains http://www.zacks.com/stock/news/226946/teva-teva-beats-on-q2-earnings-revenues-stock-gains?cid=CS-ZC-FT-226946 Aug 05, 2016 - In addition to reporting better-than-expected results, Teva (TEVA) also closed the Actavis Generics deal and announced it will be acquiring Allergan's Anda business.
Teva Pharmaceutical Industries (TEVA) Erez Vigodman on Q2 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3995942-teva-pharmaceutical-industries-teva-erez-vigodman-q2-2016-results-earnings-call-transcript?source=feed_tag_israel Aug 04, 2016 - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)Q2 2016 Earnings CallAugust 04, 2016 8:00 am ETExecutivesKevin C. Mannix - Senior Vice President, Head of Investor RelationsErez Vigodman - President, Ch
Teva Non-GAAP EPS down 13% in Q2; updates guidance http://seekingalpha.com/news/3200086-teva-non-gaap-eps-13-percent-q2-updates-guidance?source=feed_news_all Aug 04, 2016 - Teva Pharmaceutical ([[TEVA]] +0.6%) Q2 results: Revenues: $5,038M (+1.4%); R&D Expense: $375M (-2.8%); SG&A: $1,263M (+6.6%); Operating Income: $361M (-45
Allergan (AGN) Q2 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/226764/allergan-agn-q2-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-226764 Aug 04, 2016 - Allergan's (AGN) Earnings ESP, which represents the difference between the Most Accurate estimate and the Zacks Consensus Estimate, is a negative 1.49% - will the stock disappoint?
Teva (TEVA) Beats on Q2 Earnings & Revenues http://www.zacks.com/stock/news/226750/teva-teva-beats-on-q2-earnings-revenues?cid=CS-ZC-FT-226750 Aug 04, 2016 - Teva (TEVA) completed the Actavis Generics acquisition earlier this week.

Pages: 1...83848586878889909192

<<<Page 88>